Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac for pain during intravitreal injections
NCT03406689Completed
- Sponsor
- University General Hospital of Patras
- Start
- Sep 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of nepafenac in pain, sponsored by University General Hospital of Patras. Started Sep 2017; status: completed.
02
Drugs
nepafenac
03
Conditions
pain
Beyond the preview
Go deeper on NCT03406689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03406689.